La
oficina de proyectos
internacionales del IIS
Aragón ha creado este
boletín mensual mediante
el cual se va a informar
de las convocatorias de
proyectos que se
encuentran abiertas, los
eventos y las jornadas que
puedan resultar
interesantes al respecto
para el personal
investigador y de
gestión.
Si quieres contactar con
la oficina de proyectos
internacionales puedes
hacerlo a través de esta
dirección de correo
electrónico:
internacional@iisaragon.es
The
ISIDORe project
proposes to fund
Research &
Development into
preparedness and
responsiveness, by
giving scientific
communities, free-of-charge
transnational
access (TNA)
to the whole extent
of our
state-of-the-art
facilities,
cutting-edge
services, advanced
equipment and
technologies, made
available through
our catalogue of
services.
European
Join Programmes on
Rare Diseases (EJP RD)
European
Join Programmes on
Rare Diseases (EJP
RD)
Call for Proposals
2023 : «Natural
History Studies
addressing unmet
needs in Rare
Diseases”
The objective of
this call is to
conduct efficient,
innovative and
high-quality natural
history studies
which will
facilitate
understanding of the
disease’s or group
of disorders’
progression
throughout the
lifespan of a
patient. The goal of
these studies is to
collect and analyze
comprehensive
patient data to
define targets for
future therapies,
taking into
consideration
innovation, safety,
and efficacy.
Research proposals
should cover at
least one of the
following areas:
Estimation
of disease
prevalence;
Identification
of
biomarkers/companions
for the
diagnosis/prognosis
of a RD;
Identification
of
biomarkers/indicators/predictors
of a rare disease
or group of
disorders (e.g.
having the same
aetiology)
onset/progression
(including
collection of
genetic,
physiological,
environmental data
or variables….);
Identification
of relevant
endpoints for
future studies
that include
potential
biomarkers,
querying
patient-reported
outcomes (PROs)
and
quality-of-life
measures;
Identification
of
biomarkers/variables
for therapeutic
approaches
(pharmacology,
drug repurposing,
gene therapy, RNA
therapy, cell
therapy, medical
devices…).
MSCA
COFUND co-finances
new or existing
doctoral programmes
and postdoctoral
fellowship schemes
with the aim of
spreading the best
practices of the
MSCA including
international,
inter-sectoral and
interdisciplinary
research training,
as well as
international and
cross-sectoral
mobility of
researchers at all
stages of their
career.
In practice, MSCA
COFUND provides
complementary
funding for doctoral
or postdoctoral
programmes managed
by entities
established in EU
Member States or
Horizon Europe
Associated
Countries. Those
co-funded programmes
must follow MSCA’s
good practice in
terms of
international
recruitment and
minimum standard of
employment for the
recruited fellows as
described in the
European Charter for
Researchers and Code
of Conduct for the
Recruitment of
Researchers.
EU4H-2022-PJ-11:
Call for proposals
on prevention of
NCDs -
cardiovascular
diseases, diabetes
and other NCDs EU4H-2022-PJ-12:
Call for proposals
on cancer and other
NCDs prevention –
action on health
determinants EU4H-2022-PJ-14:
Call for proposals
to support the
roll-out of the
second cohort of the
inter-speciality
cancer training
programme
Call
for proposals for Mechanisms
of Resilience and
Vulnerability to
Environmental
Challenges in
Mental Health.
The aim of the call
is to facilitate
multinational,
collaborative
research projects
that will address
critical
translational
questions to improve
our knowledge
concerning
neurobiological
mechanisms involved
in resilience or
vulnerability to
environmental
challenges in mental
health.
Proposals
should aim to
address unmet needs
in the AMR
diagnostics and
surveillance sectors
beyond the current
state of the art, by
focusing on one
of the topics
of the call:
• Topic 1:
To develop novel, or
improve existing,
diagnostics,
including point of
care diagnostics,
that can rule out
antimicrobial use or
help identify the
most effective
antimicrobial
treatment.
• Topic 2:
To develop or
improve existing
strategies,
technologies or
methods, or data use
strategies to
support One Health
AMR surveillance.
MSCA
Staff Exchanges
promote innovative
international,
inter-sectoral and
interdisciplinary
collaboration in
research and
innovation through
exchanging staff and
sharing knowledge
and ideas at all
stages of the
innovation chain.
The scheme fosters a
shared culture of
research and
innovation that
welcomes and rewards
creativity and
entrepreneurship and
helps turn ideas
into innovative
products, services
or processes. It is
open to research,
technical,
administrative, and
managerial staff
supporting R&I
activities.
Horizon
Europe – Research
infrastructure
services to
support health
research,
accelerate the
green and digital
transformation,
and advance
frontier knowledge
(2023)
(HORIZON-INFRA-2023-SERV-01)
HORIZON-INFRA-2023-SERV-01-01:
Research
infrastructure
services to enable
R&I addressing
main challenges and
EU priorities.
For RI services for
improving clinical
research in the
paediatric area
• advancement of
paediatric medicines
and other
therapeutic and
diagnostic
approaches for this
population group to
markets and towards
clinical use;
• accelerated
availability of
solutions and
products to
paediatric patients
in need;
• wider access to
rationally designed
RI services across
Europe to underpin
the competitiveness
of the European
industry and of
biotech SMEs
developing
paediatric medicines
and treatment and
diagnostic devices;
• joining forces
of research
infrastructures and
paediatric
competence networks
in EU Member States
and Associated
Countries, to
facilitate
paediatric research
in the context of
pertinent EU
regulatory
environment;
• availability of
innovative tools to
conduct paediatric
clinical trials, for
the re-use of
population and
historical data, and
for enhanced data
sharing across
actors at different
care levels and
across regions in
Europe.
The aim of this call
is to develop novel
strategies and
targeted approaches
to identify,
understand, and
modify determinants
and mechanisms of
diet-related
behaviour and
physical activity as
well as sedentary
behaviour, which
have the potential
to break through the
cycles maintaining
unhealthy behaviours
and lifestyles and
to reduce health
inequalities.
Deadline of
full-proposal:
14/03/2023.
See the call text
and proposal
application form here
•
HORIZON-JU-IHI-2022-03-01:
Screening platform
and biomarkers for
prediction and
prevention of
diseases of unmet
public health need
• HORIZON-JU-IHI-2022-03-02:
Patient-generated
evidence to improve
outcomes, support
decision making, and
accelerate
innovation
• HORIZON-JU-IHI-2022-03-03:
Combining hospital
interventional
approaches to
improve patient
outcomes and
increase hospital
efficiency
• HORIZON-JU-IHI-2022-03-04:
Strengthening the
European
translational
research ecosystem
for advanced therapy
medicinal products
(ATMPs) for rare
diseases
• HORIZON-JU-IHI-2022-03-05:
Digital health
technologies for the
prevention and
personalised
management of mental
disorders and their
long-term health
consequences.
Los consorcios
solicitantes deben
asegurarse de que al
menos un 45% del
presupuesto total
está cubierto por
las contribuciones
de los participantes
en el proyecto.
•
EU4H-2022-PJ-16:
Call for proposals
to support Member
States and other
relevant actors to
implement relevant
results of
innovative public
health research in
relation to
vaccination against
COVID-19.
•
HORIZON-MISS-2023-CANCER-01-01:
Addressing
poorly-understood
tumour-host
interactions to
enhance immune
system-centred
treatment and care
interventions in
childhood,
adolescent, adult
and elderly cancer
patients.
• HORIZON-MISS-2023-CANCER-01-02:
Enhance primary
cancer prevention
through sustainable
behavioural change.
• HORIZON-MISS-2023-CANCER-01-03:
Pragmatic clinical
trials on minimally
invasive diagnostics
• HORIZON-MISS-2023-CANCER-01-04:
Establish best
practices and tools
to improve the
quality of life for
childhood cancer
patients, survivors
and their families
in European regions.
• HORIZON-HLTH-2023-ENVHLTH-02-01:
Planetary health:
understanding the
links between
environmental
degradation and
health impacts.
• HORIZON-HLTH-2023-ENVHLTH-02-02:
Evidence-based
interventions for
promotion of mental
and physical health
in changing working
environments
(post-pandemic
workplaces)
• HORIZON-HLTH-2023-ENVHLTH-02-03:
Health impacts of
endocrine-disrupting
chemicals: bridging
science-policy gaps
by addressing
persistent
scientific
uncertainties.
• HORIZON-HLTH-2023-ENVHLTH-02-04:
Global coordination
of exposome
research.
• HORIZON-HLTH-2023-DISEASE-03-01:
Novel approaches for
palliative and
end-of-life care for
non-cancer patients.
• HORIZON-HLTH-2023-DISEASE-03-03:
Interventions in
city environments to
reduce risk of
non-communicable
disease (Global
Alliance for Chronic
Diseases – GACD)
• HORIZON-HLTH-2023-DISEASE-03-04:
Pandemic
preparedness and
response: Broad
spectrum anti-viral
therapeutics for
infectious diseases
with epidemic
potential.
• HORIZON-HLTH-2023-DISEASE-03-05:
Pandemic
preparedness and
response: Sustaining
established
coordination
mechanisms for
European adaptive
platforms trials
and/or for cohort
networks.
• HORIZON-HLTH-2023-DISEASE-03-06:
Towards structuring
brain health
research in Europe.
• HORIZON-HLTH-2023-DISEASE-03-07:
Relationship between
infections and
non-communicable
diseases.
• HORIZON-HLTH-2023-DISEASE-03-17:
Pandemic
preparedness and
response:
Understanding
vaccine
induced-immunity.
• HORIZON-HLTH-2023-DISEASE-03-18:
Pandemic
preparedness and
response:
Immunogenecity of
viral proteins of
viruses with
epidemic and
pandemic potential.
Ensuring
access to
innovative,
sustainable and
high-quality
health care
(Single stage
-2023) (HORIZON-HLTH-2023-CARE-04)
• HORIZON-HLTH-2023-TOOL-05-01:
Clinical trials of
combined Advance
Therapy Medicinal
Products (ATMPs)
• HORIZON-HLTH-2023-TOOL-05-03:
Integrated,
multi-scale
computational models
of patient
patho-physiology
(‘virtual twins’)
for personalised
disease management.
• HORIZON-HLTH-2023-TOOL-05-04:
Better integration
and use of
health-related
real-world and
research data,
including genomics,
for improved
clinical outcomes.
• HORIZON-HLTH-2023-TOOL-05-05:
Harnessing the
potential of
real-time data
analysis and secure
Point-of-Care
computing for the
benefit of
person-centred
health and care
delivery.
• HORIZON-HLTH-2023-TOOL-05-08:
Pandemic
preparedness and
response: in vitro
diagnostic devices
to tackle
cross-border health
threats.
• HORIZON-HLTH-2023-TOOL-05-09:
Developing a Data
Quality and Utility
Label for the
European Health Data
Space.
• HORIZON-HLTH-2023-IND-06-01:
Supporting the
uptake of innovative
Health Technology
Assessment (HTA)
methodology and
advancing HTA
expertise across EU.
• HORIZON-HLTH-2023-IND-06-02:
Expanding the
European Electronic
Health Record
exchange Format to
improve
interoperability
within the European
Health Data Space.
• HORIZON-HLTH-2023-IND-06-04:
Modelling and
simulation to
address regulatory
needs in the
development of
orphan and
paediatric
medicines.
• HORIZON-HLTH-2023-IND-06-05:
Mapping the hurdles
for the clinical
applications of
Advanced Therapy
Medicinal Products
(ATMPs).
• HORIZON-HLTH-2023-IND-06-07:
Development and
harmonisation of
methodologies for
assessing digital
health technologies
in Europe.
•
Topic
1: Expanding
translational
knowledge in
minipigs: a path to
reduce and replace
non-human primates
in non-clinical
safety assessment
• Topic
2:
Patient-centric
blood sample
collection to enable
decentralised
clinical trials and
improve access to
healthcare
Proyectos
multinacionales de
Investigación sobre
Aspectos Éticos,
Legales y Sociales
(ELSA) de la
Neurociencia.
Las propuestas de
investigación podrán
abordar, entre
otros, los
siguientes temas:
* Consecuencias del
desarrollo de los
métodos
neurocientíficos de
diagnóstico.
* Diagnóstico en
ausencia de opciones
de tratamiento;
interacciones entre
pacientes
socioculturalmente
diversos y el
personal sanitario;
acceso (equitativo)
a métodos novedosos
y caros; uso no
intencionado y/o uso
indebido).
* Aspectos de
investigación
clínica con
pacientes que
padecen enfermedades
neurológicas o
psiquiátricas.
* Tecnologías
inteligentes y
estrecha interacción
entre el ser humano
y la máquina.
* Biobancos de
tejidos neuronales.
* Utilización de
datos cerebrales;
intervenciones
cerebrales en
contextos jurídicos.
* Impacto de la
neurociencia moderna
en las cuestiones,
conceptos y teorías
filosóficas
tradicionales sobre
aspectos
fundamentales de la
naturaleza humana.
* Cambios sociales y
culturales inducidos
por el conocimiento
neurocientífico y su
aplicación.
* Investigación e
innovación
responsables en
neurotecnología y
neurociencia.
•
ERC-2023-ADG:
ERC Advanced Grants
are designed to
support excellent
Principal
Investigators at the
career stage at
which they are
already established
research leaders
with a recognised
track record of
research
achievements.
Principal
Investigators must
demonstrate the
ground-breaking
nature, ambition and
feasibility of their
scientific
proposal.
•
HORIZON-MISS-2023-CLIMA-01-03:
Testing and
demonstrating
transformative
solutions to build
resilience towards
health risks caused
by the effects of
climate change.
EJP
RD – European Joint
Programme on Rare Diseases
– 13-17/02/2023 12 :00 –
17 :00 Barcelona, Spain
Registration is now open
to the yearly 5-day course
on “Translational Medicine
Explained (TMex) ” on 13-17
February 2023 in
Barcelona. The
course is intended for
PhD/MD students, postdocs
and other young scientists
who are involved in
biomedical research and
want to learn more about
Translational Medicine.
The TMex (“Translational
Medicine Explained)”
Winter School consists of
an introductory e learning
(~12 hours student
investment time) followed
by a 5-day face-to-face
workshop. The course is
intended for PhD/MD
students in the second
half of their PhD and
postdocs who are involved
in biomedical research.
The full fee is of 650€.
Special discounted fees of
475€ applies for EATRIS
members and I2TRON
students, and of 250€ for
VHIR students and EUPATI
fellows.
There are only 30 seats,
so we recommend applying
early (first come, first
served).
The registration
will close when all
seats have been filled.
You will need to submit a
biosketch and a motivation
letter which will be
reviewed by a selection
committee.
El
evento de lanzamiento del
POCTEFA 2021-2027 tendrá
lugar el 8 de marzo en
Vitoria-Gasteiz (Palacio
de Congresos Europa). Se
tratará de un evento de un
día (mañana y tarde) en el
que se darán a conocer las
novedades del POCTEFA
2021-2027. Se explicarán
los objetivos, territorio,
dotación FEDER, el nuevo
SIGEFA y prioridades,
entre otros temas
relacionados con este
nuevo periodo.
El programa POCTEFA ofrece
posibilidades de
financiación para
proyectos transfronterizos
liderados por actores del
sector público y privado
de la zona de cooperación.
Las entidades
beneficiarias pueden ser
organismos públicos,
empresas, agencias de
desarrollo, agrupaciones,
asociaciones, fundaciones,
cámaras de comercio o
centros de enseñanza,
entre otros tipos de
entidades o agrupaciones.
También se presentará la
1ª convocatoria de
proyectos del POCTEFA
2021-2027 que se abrirá
previsiblemente en fechas
cercanas al evento. Se
abordarán temas como
fechas, características,
el formulario de
candidatura, etc.
El texto del Programa
POCTEFA 2021-2027 fue
aprobado por la Comisión
Europea el 23 de noviembre
de 2022 y está
disponible aquí.
La dotación de la Unión
Europea a través del Fondo
Europeo de Desarrollo
Regional (FEDER) concedida
al POCTEFA 2021-2027 es de
243 millones de
euros. El
programa se organiza en
siete prioridades; cuatro
objetivos políticos y un
objetivo INTERREG; y
quince objetivos
específicos.
Interregional
cooperation forum – 15
March 2023 – Stockholm,
Sweden
The 9th edition of Europe,
let's cooperate!
interregional
cooperation forum takes
place on 15 March 2023
in Stockholm (Sweden).
The day focuses on
launching the second
call for project
proposals in
2021-2027 and helping you
get ready for new
interregional cooperation
projects.
What to expect:
• Inspiration
and ideas for
new projects
• Information about the
second call
• Networking opportunities
to find
cooperation partners
• Individual
meetings with the joint
secretariat to
discuss your call-related
questions
Register now to be part of
the event and meet
policymakers, experts and
people involved in
regional development from
all across Europe.
Contacto
Instituto de Investigación
Sanitaria Aragón (IIS Aragón)
Centro de Investigación
Biomédica de Aragón (CIBA)
Avda. San Juan Bosco, nº 13.
50009 - Zaragoza
Tfno. +34 976 71 64 17 | +34 976
71 44 02
Recibes este boletín porque eres
miembro del IIS Aragón o porque
estás interesado en sus
actividades. Si no deseas
recibirlo, por favor, ponte en
contacto con internacional@iisaragon.es
para tramitar la baja de la
suscripción.
